Healthcare act affirmed; Synapse adds jobs in Ohio; Efficiencies drive GSK inhaler plant;

> In a surprise decision, the Supreme Court has upheld the affordable healthcare act. Story

> Devicemaker Synapse Biomedical is using a $5.1 million state tax break to add 60 jobs to its Oberlin, OH, plant. Story

> Six workers can now handle four assembly lines that turn out 220,000 inhalers a day because of efficiencies built into GlaxoSmithKline's ($GSK) respiratory-drug plant in Ware, England. Story

> Suzhou Pharma will open a quality assurance operation in Lyndhurst, NJ, in an effort to marry Western cGMP know-how with Asian production expertise. Story

And Finally... The FDA user fee law bans 28 chemicals sold at corner stores as hygiene products, incense or plant food that are often used in synthetic drugs known as "bath salts." Story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.